Table 1.
Baseline details of studies.
| Standard graphical abstract | Three facts and a story | |
|---|---|---|
| Type | ||
| Original | 29 (94%) | 21 (91%) |
| Review | 2 (6%) | 3 (9%) |
|
| ||
| Clinical science | 17 (55%) | 14 (61%) |
|
| ||
| Clinical trial | 3 (10%) | 1 (4%) |
|
| ||
| Topic | ||
| Non-alcoholic fatty liver disease | 2 (6%) | 1 (4%) |
| Alcohol-related liver disease | 0 (0%) | 1 (4%) |
| Viral hepatitis | 5 (16%) | 5 (17%) |
| Autoimmune hepatitis | 0 (0%) | 1 (4%) |
| Cholestatic liver disease | 2 (6%) | 0 (0%) |
| Cirrhosis management | 5 (16%) | 3 (13%) |
| Liver cancer | 7 (23%) | 8 (35%) |
| Metabolism/signaling | 6 (19%) | 5 (22%) |
| Liver transplant | 3 (10%) | 0 (0%) |